Nandini Selvam, PhD, MPH

VP & GM
IQVIA
Ashburn, United States

Disclosure information not submitted.

Presentation(s):

• Evaluation of Febrile Seizure Risk Following Ancestral Monovalent COVID-19 mRNA Vaccination Among U.S. Children Aged 2-5 Years

  Monday, August 26, 2024
  2:15 PM – 2:30 PM CEST